Floatz logo

Vivomixx

Cirrhosis of the Liver

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

143 Active assets in the Cirrhosis of the Liver cohort.

Asset / SponsorPhaseRating
PARITAPREVIR
AbbVie
Phase 3A
GLY-GLY-GLY-CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (4-9 DISULFIDE)
General Hospital of Shenyang Military Region
Phase 4BBB
Tolvaptan
Institute of Liver and Biliary Sciences, India
Phase 4BBB
Ribavirin
Peking University People's Hospital
Phase 4BBB
NORMAL HUMAN SERUM ALBUMIN
King George's Medical University
Phase 4BBB

View all 50 →

Same molecule, other indications

Vivomixx is also rated in:

celiac diseaseDormant
BB
Indicative ·
65 / 100
View asset →
peritonitisDormant
B
Indicative ·
60 / 100
View asset →
breast cancerDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →